Page last updated: 2024-11-06

triethylenemelamine and Chronic Disease

triethylenemelamine has been researched along with Chronic Disease in 4 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"Urethane is the best treatment available for multiple myeloma."1.23New therapy for leukemia, polycythemia, and lymphoma. ( BARTLETT, GR; MARLOW, AA, 1953)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MARLOW, AA1
BARTLETT, GR1
NEUMANN, C1
HAEHNER, E1
HEINEN, W1
LOOSEN, H1
SCHMIDT, H1
MEZA ARRAU, C1
NIJAMKIN, A1

Other Studies

4 other studies available for triethylenemelamine and Chronic Disease

ArticleYear
New therapy for leukemia, polycythemia, and lymphoma.
    California medicine, 1953, Volume: 78, Issue:2

    Topics: Aminopterin; Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Multiple

1953
[Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
    Klinische Wochenschrift, 1952, Dec-15, Volume: 30, Issue:47-48

    Topics: Chronic Disease; Cytostatic Agents; Hodgkin Disease; Leukemia; Sarcoidosis; Triethylenemelamine

1952
[Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma].
    Medizinische Klinik, 1954, May-21, Volume: 49, Issue:21

    Topics: Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Triethylenemelamine

1954
[Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias].
    Revista medica de Chile, 1955, Volume: 83, Issue:2

    Topics: Chronic Disease; Hodgkin Disease; Leukemia; Lymphoma; Triethylenemelamine

1955